Viking Therapeutics Announces Appointment of Hubert C. Chen, M.D., as Chief Medical Officer
Viking Therapeutics appointed Hubert C. Chen, M.D., as its new Chief Medical Officer, effective immediately. Dr. Chen brings over two decades of experience, including leading obesity and type 2 diabetes programs at Amylin Pharmaceuticals and securing FDA approvals for drug-device combinations at Pfenex.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.